1800 202 8726
Targeted therapy for blood cancers

Ibrutinib (Imbruvica, Ibrutix): — The Complete Patient Guide

Ibrutinib is a once-daily tablet prescribed for blood cancers including chronic lymphocytic leukaemia and certain lymphomas. If it has just been prescribed to you, this page explains what it does, what to expect while you are on it, and what to watch for.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026

  • A targeted therapy, not chemotherapy — Ibrutinib blocks a specific protein cancer cells need to survive, rather than attacking all fast-growing cells.
  • Taken at home, once a day — You swallow a capsule or tablet at the same time each day. There are no IV infusions for ibrutinib itself.
  • Taken continuously — Unlike chemotherapy cycles, you take ibrutinib every day for as long as it is working and you are tolerating it.
  • Drug interactions are a real concern — Several common medicines, including some antifungals and heart drugs, can change how ibrutinib works in your body.
4.8 · 800+ Google reviews · 15,000+ patients treated
Limited Slots Today

Get this explained properly

₹950   Today: FREE  ·  Including free written second opinion

Reply within 2 working hours
Reviewed by a senior medical oncologist
Confidential. No commitment to start treatment.
or
Call 1800 202 8726
17+
Cancer Specialists
on Panel
96.9%
Breast Cancer
Survival Rate*
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

Ibrutinib is a tablet taken once a day for certain blood cancers, including chronic lymphocytic leukaemia and lymphoma. It works by blocking a protein called BTK that cancer cells need to grow and survive. You take it continuously, not in cycles. Most people manage it at home alongside their normal daily life.

What is ibrutinib and which cancers is it used for?

Ibrutinib belongs to a class of drugs called BTK inhibitors. BTK is a protein that certain blood cancer cells depend on to grow and multiply. By blocking BTK, ibrutinib cuts off a signal the cancer cells need to survive.

It is most often prescribed for chronic lymphocytic leukaemia, small lymphocytic lymphoma, mantle cell lymphoma, Waldenström's macroglobulinaemia, and marginal zone lymphoma. Your oncologist will have told you which condition is being treated.

It is not chemotherapy. It targets a specific molecular switch rather than attacking all rapidly dividing cells. That is why the side effect pattern differs from what most people associate with cancer treatment.

Tell your doctor before you start ibrutinib

  • Any blood thinners, aspirin, or anti-inflammatory pain medicines — ibrutinib increases bleeding risk and these add to it
  • Any antifungal medicines (fluconazole, itraconazole, voriconazole) — these significantly raise ibrutinib levels in your body
  • Any heart rhythm medicines, or a history of atrial fibrillation or heart failure
  • Any herbal supplements, including St John's Wort and turmeric taken in large medicinal amounts
  • A planned surgery, dental extraction, or invasive procedure — ibrutinib may need to be paused beforehand
  • Whether you are pregnant, planning a pregnancy, or breastfeeding

How do you take ibrutinib?

You take ibrutinib once a day at roughly the same time. It can be taken with or without food. Swallow the capsule or tablet whole — do not open, crush, or chew it.

If you miss a dose and remember on the same day, take it as soon as you can. If you only remember the following day, skip that dose and return to your normal schedule — never take two doses together to make up for one missed.

Avoid grapefruit and Seville orange juice while on ibrutinib. These fruits block an enzyme that breaks down the drug, which can push levels in your body to an unpredictable range.

Still unclear?

Send your reports across and a specialist will walk you through what they mean — what is known, what is not, and what the options actually are.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

Words your team may use

BTK (Bruton's tyrosine kinase)
A protein inside B-cells that acts like a growth switch. Ibrutinib blocks this switch.
CLL (Chronic lymphocytic leukaemia)
A slow-growing blood cancer where the body makes too many abnormal white blood cells called B-lymphocytes. One of the most common reasons ibrutinib is prescribed.
MCL (Mantle cell lymphoma)
A type of non-Hodgkin lymphoma. Ibrutinib is used when it has returned after earlier treatment.
WM (Waldenström's macroglobulinaemia)
A rare lymphoma that produces an abnormal protein called IgM. Ibrutinib is an established treatment option.
Atrial fibrillation (AF)
An irregular heart rhythm. It occurs more often in people on ibrutinib than in the general population, and your team will watch for it.
Response
A measurable reduction in cancer activity. Your team monitors blood counts and scans to assess how well ibrutinib is working for you.

What side effects should you know about?

Bruising and bleeding more easily than usual is common on ibrutinib, because BTK also plays a role in how platelets clump together. Minor bruising is expected. Unusual bleeding, blood in your urine or stools, or a cut that will not stop needs a call to your team.

Diarrhoea, particularly in the first weeks, is reported by a proportion of patients and usually settles. If it is frequent, contains blood, or comes with fever, call your team the same day.

Heart rhythm changes, including atrial fibrillation, occur in a proportion of patients. Palpitations, an irregular heartbeat, shortness of breath, or light-headedness need prompt contact with your team.

Any fever, chills, or signs of infection — a cough getting worse, redness at a wound site — need same-day contact, because ibrutinib reduces the immune system's ability to fight infection.

Questions people commonly ask about ibrutinib

How long will I take ibrutinib?

Ibrutinib is taken continuously for as long as it is controlling your cancer and you are tolerating it. There is no fixed number of cycles or a pre-set end date. Some people take it for years. Your oncologist will monitor your response through regular blood tests and, where appropriate, scans. The decision to stop or switch is based on whether the cancer is responding and how your body is managing the drug — not a calendar.

Will ibrutinib make me lose my hair?

Hair loss is not a typical side effect of ibrutinib. It works very differently from standard chemotherapy, which attacks all fast-dividing cells including hair follicles. Some people notice mild thinning, but significant hair loss is not expected. If you are receiving another treatment alongside ibrutinib, that other treatment may have its own hair effects — ask your team to clarify which side effects belong to which medicine in your particular regimen.

I need surgery. Do I have to stop ibrutinib?

In most cases, yes — ibrutinib is paused around surgery because it raises bleeding risk. The timing of when to stop and when to restart depends on the type of procedure and your oncologist's guidance, and your surgical team and oncology team need to plan this together. Tell both teams you are on ibrutinib before any procedure is scheduled, including dental extractions, which carry a real bleeding risk. Do not stop ibrutinib on your own without that conversation.

Can I drink alcohol on ibrutinib?

There is no absolute rule, but alcohol adds to the bleeding risk that ibrutinib already carries and can worsen diarrhoea. Some people on ibrutinib are advised to avoid it entirely because of their other medicines or their liver function — your team can tell you what applies specifically to you. If you do drink, keep it to a minimum and mention it at your next appointment so it can be factored into your monitoring.

Why does it matter which antifungal I take?

Ibrutinib is broken down by a liver enzyme called CYP3A4. Several antifungals — including fluconazole, itraconazole, and voriconazole — block this enzyme strongly, which means ibrutinib cannot clear normally and builds up in your body to an unpredictable level. This raises both the intended effect and the risk of side effects. If you develop a fungal infection while on ibrutinib, your team will either choose an antifungal that does not interact or pause ibrutinib. Do not start any antifungal without telling your oncology team first.

What monitoring will I need while on ibrutinib?

Your team will check your full blood count regularly to track how your blood cells are responding, and will also monitor your kidney and liver function. Heart rhythm monitoring may be done at some centres, particularly if you are older or have existing heart conditions. The frequency of tests is highest at the start of treatment and often reduces once things are stable. Keeping these appointments matters — some early changes show up on tests before you notice any symptom, which is exactly when they are easiest to manage.

Explore 75 more Blood Cancer Targeted Medicines topics

Drug Deep Dive: Ibrutinib (Imbruvica)

All Blood Cancer Targeted Medicines →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726
Common questions

Frequently asked questions

Is ibrutinib a form of chemotherapy?

No. Ibrutinib is a targeted therapy, not chemotherapy. It works by blocking a specific protein called BTK that blood cancer cells depend on to grow. Chemotherapy attacks all rapidly dividing cells, which is why it commonly causes hair loss, mouth sores and severe fatigue. Ibrutinib has its own side effects — bruising, diarrhoea, and heart rhythm changes among them — but the pattern is different. Your oncologist can walk you through what to specifically expect on ibrutinib.

What happens if ibrutinib stops working?

If ibrutinib is no longer controlling your cancer, your oncologist will discuss alternatives. For several blood cancers, other BTK inhibitors or drugs with different mechanisms are available, and the options depend on your diagnosis, how your cancer has behaved, and your overall fitness. Not every patient reaches this point — many continue on ibrutinib for years. It is reasonable to ask your oncologist early what the next step would be if needed, and a good oncologist will answer that directly.

Can I take ibrutinib with my other regular medicines?

Ibrutinib interacts with several common medicines, including some antifungals, certain antibiotics, some heart medicines, and blood thinners. The interaction goes both ways — ibrutinib can also affect how other drugs work in your body. Tell your oncologist and your family doctor every medicine you take, including medicines bought without a prescription, vitamins, and herbal preparations. Your pharmacist can also check for interactions. Do not start or stop any medicine without checking first.

What does ibrutinib cost in India?

The cost varies depending on the brand — Imbruvica is the originator brand and Ibrutix is among the generics available in India — and the dose prescribed. Any figure quoted is indicative and changes over time. Ask your oncology team about manufacturer assistance programmes, government schemes, or insurance coverage that may apply to your situation. A social worker or patient navigator at your centre can help identify what you are eligible for.

Can I travel while I am on ibrutinib?

Most people on ibrutinib can travel. The practical steps are: carry enough tablets for the full trip with a few extra in case of delays, keep them in their original packaging, store them away from heat and humidity, and carry a letter from your oncologist if you are asked about the medicine at customs. If you are travelling to a region where malaria prevention is needed, tell your oncologist before starting any anti-malarial, as some interact with ibrutinib.

Will ibrutinib affect my fertility?

Animal studies have shown ibrutinib can harm a developing foetus, so it is not considered safe in pregnancy. Women who could become pregnant are advised to use effective contraception during treatment and for a period after stopping — your team will specify the timing. Men considering fathering children while on ibrutinib should raise this before starting treatment, as fertility preservation may be worth discussing. Ask your oncologist for guidance that applies to your individual situation.

Call now Book free consultation